1. Guanidine Derivatives Containing the Chalcone Skeleton Are Potent Antiproliferative Compounds against Human Leukemia Cells.
- Author
-
Estévez-Sarmiento F, Saavedra E, Brouard I, Peyrac J, Hernández-Garcés J, García C, Quintana J, and Estévez F
- Subjects
- Humans, Apoptosis, Cell Line, Tumor, Cell Proliferation, Guanidine pharmacology, Leukocytes, Mononuclear metabolism, Proto-Oncogene Proteins c-bcl-2, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Chalcones pharmacology, Leukemia drug therapy, Leukemia metabolism, Melanoma drug therapy
- Abstract
In this study, we investigated the effects of eleven synthetic guanidines containing the 1,3-diphenylpropenone core on the viabilities of six human cancer cells. The most cytotoxic compound against human cancer cells of this series contains a N -tosyl group and a N -methylpiperazine moiety 6f . It was cytotoxic against leukemia cells (U-937, HL-60, MOLT-3, and NALM-6) with significant effects against Bcl-2-overexpressing U-937/Bcl-2 cells as well as the human melanoma SK-MEL-1 cell line. It exhibited low cytotoxicity against quiescent or proliferating human peripheral blood mononuclear cells. The IC
50 value for the leukemia U-937 cells was 1.6 ± 0.6 µM, a similar value to that in the antineoplastic agent etoposide. The guanidine containing a N -phenyl substituent 6i was also as cytotoxic as the guanidine containing the N -tosyl substituent and the N -methylpiperazine group 6f against human U-937 leukemia cells and both synthetic guanidines were potent apoptotic inducers. Cell death was mediated by the activation of the initiator caspase-9 and the executioner caspase-3, and associated with the release of cytochrome c . These synthetic guanidines are potent cytotoxic compounds against several human leukemia cells and even the human melanoma cell line SK-MEL-1 and might be useful in the development of new strategies in the fight against cancer.- Published
- 2022
- Full Text
- View/download PDF